Current and historical daily PE Ratio for Ibex Technologies Inc (
TSXV:IBT
) from 1990 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ibex Technologies stock (TSXV:IBT) PE ratio as of Jun 07 2024 is 9.47.
More Details
Ibex Technologies Inc (TSXV:IBT) PE Ratio (TTM) Chart
Ibex Technologies Inc (TSXV:IBT) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Ibex Technologies PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | 9.5 | 2024-02-06 | 7.6 |
| 2024-04-10 | 9.5 | 2024-02-05 | 7.4 |
| 2024-04-09 | 9.5 | 2024-02-02 | 7.4 |
| 2024-04-08 | 9.5 | 2024-02-01 | 7.6 |
| 2024-04-05 | 9.5 | 2024-01-31 | 7.4 |
| 2024-04-04 | 9.5 | 2024-01-30 | 7.4 |
| 2024-04-03 | 9.5 | 2024-01-29 | 7.5 |
| 2024-04-02 | 9.5 | 2024-01-26 | 7.4 |
| 2024-04-01 | 9.5 | 2024-01-25 | 7.5 |
| 2024-03-28 | 9.4 | 2024-01-24 | 7.4 |
| 2024-03-27 | 9.4 | 2024-01-23 | 7.0 |
| 2024-03-26 | 9.4 | 2024-01-22 | 7.0 |
| 2024-03-25 | 9.4 | 2024-01-19 | 7.0 |
| 2024-03-22 | 9.4 | 2024-01-18 | 7.0 |
| 2024-03-21 | 9.4 | 2024-01-17 | 7.0 |
| 2024-03-20 | 9.4 | 2024-01-16 | 7.0 |
| 2024-03-19 | 9.3 | 2024-01-15 | 7.2 |
| 2024-03-18 | 9.3 | 2024-01-12 | 7.2 |
| 2024-03-15 | 9.3 | 2024-01-11 | 7.4 |
| 2024-03-14 | 9.4 | 2024-01-10 | 7.1 |
| 2024-03-13 | 9.4 | 2024-01-09 | 7.1 |
| 2024-03-12 | 9.4 | 2024-01-08 | 7.1 |
| 2024-03-11 | 9.3 | 2024-01-05 | 7.4 |
| 2024-03-08 | 9.3 | 2024-01-04 | 7.5 |
| 2024-03-07 | 9.3 | 2024-01-03 | 7.5 |
| 2024-03-06 | 9.4 | 2024-01-02 | 7.5 |
| 2024-03-05 | 9.3 | 2023-12-29 | 7.7 |
| 2024-03-04 | 9.4 | 2023-12-28 | 7.7 |
| 2024-03-01 | 9.4 | 2023-12-27 | 7.3 |
| 2024-02-29 | 9.2 | 2023-12-22 | 7.4 |
| 2024-02-28 | 9.3 | 2023-12-21 | 7.4 |
| 2024-02-27 | 9.3 | 2023-12-20 | 7.2 |
| 2024-02-26 | 9.3 | 2023-12-19 | 7.0 |
| 2024-02-23 | 9.3 | 2023-12-18 | 7.1 |
| 2024-02-22 | 9.3 | 2023-12-15 | 6.6 |
| 2024-02-21 | 9.3 | 2023-12-14 | 7.1 |
| 2024-02-20 | 9.3 | 2023-12-13 | 6.0 |
| 2024-02-16 | 9.3 | 2023-12-12 | 5.7 |
| 2024-02-15 | 9.3 | 2023-12-11 | 5.7 |
| 2024-02-14 | 9.3 | 2023-12-08 | 5.7 |
| 2024-02-13 | 9.3 | 2023-12-07 | 5.8 |
| 2024-02-12 | 9.3 | 2023-12-06 | 5.8 |
| 2024-02-09 | 7.4 | 2023-12-05 | 5.6 |
| 2024-02-08 | 7.4 | 2023-12-04 | 5.5 |
| 2024-02-07 | 7.6 | 2023-12-01 | 5.3 |
Ibex Technologies Inc (TSXV:IBT) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Ibex Technologies Inc
NAICS : 325412
SIC : 3741
ISIN : CA4489375085
Compare
Compare
Traded in other countries / regions
IBT.CanadaIBT.GermanyIBXNF.USA IPO Date
1986-12-22Description
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers